National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Division of Sexually Transmitted Diseases
Program and Training Branch
Resources
Publications
Allsworth JE, Peipert JF. Prevalence of bacterial
vaginosis: 2001-2004 National Health and Nutrition
Examination Survey Data. Obstet Gynecol. 2007 Jan;
109(1):114-20.
American Social Health Association. Sexually transmitted
diseases in America: How many cases and at what cost? Menlo
Park (CA): Kaiser Family Foundation; 1998. Available from
URL: http://www.ashastd.org/pdfs/std_rep.pdf .
Berger BJ, et al. Bacterial vaginosis in lesbians: a
sexually transmitted disease. Clin Infect Dis 1995;
21:1402-5.
Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G.
Safety of metronidazole in pregnancy: a meta-analysis.
Obstet Gynecol 1995; 172:525–9.
Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to
prevent preterm delivery in pregnant women with asymptomatic
bacterial vaginosis. N Engl J Med 2000; 342:534–40.
Hauth JC, et al. Reduced incidence of preterm delivery
with metronidazole and erythromycin in women with bacterial
vaginosis. New Engl J Med 1995; 333:1732-1736.
Hay P, Ugwumadu AHN, Manyonda IT. Oral clindamycin
prevents spontaneous preterm birth and mid trimester
miscarriage in pregnant women with bacterial vaginosis. Int
J STD AIDS 2001;12 (Suppl 2):70-1.
Hillier SL, et al. Association between bacterial
vaginosis and pre-term delivery of a low-birth weight
infant. New Engl J Med 1995; 333:1737-1742.
Klebanoff MA, Carey JC, Hauth JC, et al. Failure of
metronidazole to prevent preterm delivery among pregnant
women with asymptomatic Trichomonas vaginalis infection. N
Engl J Med 2001;345:487–93.
Krieger JN. Trichomoniasis in men: old issues and new
data. Sex Transm Dis 1995; 22:83-96.
Larsson P-G, et al. Incidence of pelvic inflammatory
disease after first trimester legal abortion with bacterial
vaginosis after treatment with metronidazole: a double-blind
randomized study. Am J Obstet Gynecol 1992; 166:100-103.
Miller WC, Swygard H, Hobbs MM, et al. The prevalence of
trichomoniasis in young adults in the United States. Sex
Transm Dis 2005; 32:593-8.
Schwebke JR, Desmond R. Risk factors for bacterial
vaginosis in women at high risk for sexually transmitted
diseases. Sex Transm Dis 2005; 32(11):654-8.
Sewankambo N, et al. HIV-1 infection associated with
abnormal vaginal flora morphology and bacterial vaginosis.
Lancet 1997; 350:546-550.
Skinner CJ. A case-controlled study of the sexual needs
of lesbians. Genitourin Med 1996; 72:277-280.
Sobel J, Peipert JF, McGregor JA, et al. Efficacy of
clindamycin vaginal ovule (3-day treatment) vs. clindamycin
vaginal cream (7-day treatment) in bacterial vaginosis.
Infect Dis Obstet Gynecol 2001; 9:9–15.
Sobel JD, Ferris D, Schwebke J, et al. Suppressive
antibacterial therapy with 0.75% metronidazole vaginal gel
to prevent recurrent bacterial vaginosis. Am J Obstet
Gynecol 2006;194:1283–9.
U.S. Preventive Services Task Force. Screening for
bacterial vaginosis in pregnancy to prevent preterm
delivery: U.S. Preventive Services Task Force recommendation
statement. Ann Intern Med. 2008 Feb 5; 148(3):214-9.
Van Der Pol B, Williams JA, Orr DP, Batteiger BE,
Fortenberry JD. Prevalence, incidence, natural history, and
response to treatment of Trichomonas vaginalis infection
among adolescent women. J Infect Dis 2005; 192:2039-44.
Wasserheit JN. Epidemiologic synergy: interrelationships
between human immunodeficiency virus infection and other
sexually transmitted diseases. Sex Transm Dis 1992;
19:61-77.
Weinstock H, Berman S, Cates W Jr. Sexually transmitted
diseases among American youth: incidence and prevalence
estimates, 2000. Perspect Sex Repro Hlth 2004; 36 (1): 6-10.
Wendel KA, Workowski KA. Trichomoniasis: Challenges to
Appropriate Management. Clin Infect Dis 2007; 44 (Suppl
3):S123-9.